Diffuse large B-cell lymphoma unclassifiable

Clinical trials for Diffuse large B-cell lymphoma unclassifiable explained in plain language.

Never miss a new study

Get alerted when new Diffuse large B-cell lymphoma unclassifiable trials appear

Sign up with your email to follow new studies for Diffuse large B-cell lymphoma unclassifiable, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for tough lymphoma: targeted drug combo shows promise in early trial

Disease control Ongoing

This phase 2 trial tests a combination of the targeted drug polatuzumab vedotin with standard chemotherapy (rituximab, ifosfamide, carboplatin, and etoposide) as an initial salvage therapy for patients with diffuse large B-cell lymphoma that has relapsed or not responded to treat…

Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA UNCLASSIFIABLE

Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Diffuse large B-cell lymphoma unclassifiable

Get alerted when new Diffuse large B-cell lymphoma unclassifiable trials appear

New hope for tough lymphoma: targeted drug combo shows promise in early trial